20 ML bupivacaine liposome 13.3 MG/ML Injection

RxCUI: 1191508
RxNorm name: 20 ML bupivacaine liposome 13.3 MG/ML Injection
Display name: BUPivacaine (Injectable)
Full name: 20 ML bupivacaine liposome 13.3 MG/ML Injection
Term type: SCD
Status: Active
Strength: 13.3 mg/ml
Dose form: Injection 20 ml
Route: Injectable
Updated: 2026-10-27 17:47:44

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 122011
Active start: 122011
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
bupivacaine	13.3 MG / 1 ML	bupivacaine	bupivacaine

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Injection	1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
bupivacaine	1815

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	20 ML BUPivacaine liposome 13.3 MG/ML Injection	1	NAMES
RxNorm Name	20 ML bupivacaine liposome 13.3 MG/ML Injection	1	NAMES
RxNorm Synonym	2 linked values bupivacaine liposome 1.3 % in 20 ML Injection bupivacaine liposome 266 MG per 20 ML Injection	2	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	0af296bb-1599-4b35-b66b-994924d3e898	1	CODES
RxCUI	1191508	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
57884-3252-1	57884-3252	Bupivacaine Bupivacaine	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	ANDA214348

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA214348	57884-3252	Bupivacaine Bupivacaine	ANDA	Jiangsu Hengrui Pharmaceuticals Co., Ltd.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
57884325201	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EXPAREL	BUPIVACAINE	Pacira Pharmaceuticals, Inc.	bb5a9e59-0f51-11df-8a39-0800200c9a66	2025-12-12	Warnings, Adverse reactions	Exact identifier rxcui: 1191508
Bupivacaine	BUPIVACAINE	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	0af296bb-1599-4b35-b66b-994924d3e898	2024-07-09	Warnings, Adverse reactions	Exact identifier ndc (package): 57884-3252-1 ndc (product): 57884-3252 ndc11 (package): 57884325201 rxcui: 1191508

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
bb5a9e59-0f51-11df-8a39-0800200c9a66	BUPivacaine liposome 1.3 % in 20 ML Injection [PSN] · 20 ML bupivacaine liposome 13.3 MG/ML Injection [SCD] · bupivacaine liposome 1.3 % in 20 ML Injection [SY] · bupivacaine liposome 266 MG per 20 ML Injection [SY]	4	32	These highlights do not include all the information needed to use EXPAREL® safely and effectively. See full prescribing information for EXPAREL. EXPAREL (bupivacaine liposome injectable suspension), for infiltration or perineural use Initial U.S. Approval: 1972	20251212
0af296bb-1599-4b35-b66b-994924d3e898	BUPivacaine liposome 1.3 % in 20 ML Injection [PSN] · 20 ML bupivacaine liposome 13.3 MG/ML Injection [SCD] · bupivacaine liposome 1.3 % in 20 ML Injection [SY] · bupivacaine liposome 266 MG per 20 ML Injection [SY]	4	4	These highlights do not include all the information needed to use BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION safely and effectively. See full prescribing information for BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION. BUPIVACAINE LIPOSOME injectable suspension, for infiltration or perineural use Initial U.S. Approval: 1972	20240709

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
0af296bb-1599-4b35-b66b-994924d3e898	These highlights do not include all the information needed to use BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION safely and effectively. See full prescribing information for BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION. BUPIVACAINE LIPOSOME injectable suspension, for infiltration or perineural use Initial U.S. Approval: 1972	Jiangsu Hengrui Pharmaceuticals Co., Ltd. \| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) \| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)	20240709

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N01BB	Amides	ATC1-4		bupivacaine
FDASPL	D000577	Amides	CHEM	has_chemical_structure	bupivacaine
FDASPL	N0000175682	Amide Local Anesthetic	EPC	has_epc	bupivacaine
FDASPL	N0000175976	Local Anesthesia	PE	has_pe	bupivacaine
MEDRT	D002045	Bupivacaine	CHEM	has_ingredient	bupivacaine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	bupivacaine
MEDRT	D010146	Pain	DISEASE	may_prevent	bupivacaine
MEDRT	D010149	Postoperative Pain	DISEASE	may_treat	bupivacaine
MEDRT	N0000000108	Prostaglandin Receptor Antagonists	MOA	has_moa	bupivacaine
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	bupivacaine
MEDRT	N0000008768	Decreased Organized Electrical Activity	PE	has_pe	bupivacaine
MEDRT	N0000175976	Local Anesthesia	PE	has_pe	bupivacaine

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Exparel	rxnav_allrelated
DF	DF	Injection	rxnav_allrelated
DFG	DFG	Injectable Product	rxnav_allrelated
IN	IN	bupivacaine	rxnav_allrelated
PIN	PIN	bupivacaine liposome	rxnav_allrelated
SBD	SBD	20 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel]	rxnav_allrelated
SBDC	SBDC	bupivacaine liposome 13.3 MG/ML [Exparel]	rxnav_allrelated
SBDF	SBDF	bupivacaine Injection [Exparel]	rxnav_allrelated
SBDFP	SBDFP	bupivacaine liposome Injection [Exparel]	rxnav_allrelated
SBDG	SBDG	Exparel Injectable Product	rxnav_allrelated
SCD	SCD	20 ML bupivacaine liposome 13.3 MG/ML Injection	rxnav_allrelated
SCDC	SCDC	bupivacaine liposome 13.3 MG/ML	rxnav_allrelated
SCDF	SCDF	bupivacaine Injection	rxnav_allrelated
SCDFP	SCDFP	bupivacaine liposome Injection	rxnav_allrelated
SCDG	SCDG	bupivacaine Injectable Product	rxnav_allrelated
SCDGP	SCDGP	bupivacaine liposome Injectable Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	13.3 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	20 ML
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA214348
CODES	VUID	4031619
NAMES	Prescribable Synonym	BUPivacaine liposome 1.3 % in 20 ML Injection
NAMES	Tallman Synonym	20 ML BUPivacaine liposome 13.3 MG/ML Injection
NAMES	Tallman Synonym	BUPivacaine liposome 1.3 % in 20 ML Injection
NAMES	Tallman Synonym	BUPivacaine liposome 266 MG per 20 ML Injection
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File